EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

OPEN ACCESS - PLEASE RSVP TO RESERVE YOUR SEAT

Drivers of innovation: Evolving models in rare disease drug development

Tuesday, January 9, 4:30-5:30 pm
Hilton San Francisco Union Square

The growing pressure on drug companies to bring new rare disease therapies quickly and cost-effectively is giving rise to a variety of emerging business models. While there are a number of fully integrated pharmaceutical companies in the space, others are focusing on licensing a platform technology, acting more like an incubator, or driving an array of projects through a collaboration model. What do companies gain or lose through such strategies? How do they accelerate the development of new therapies? How do investors view these models?

Media roundup: Heard around the square

Wednesday, January 10, 4:30-5:15 pm
Hilton San Francisco Union Square

As the intensity of this all important week in the biotech and healthcare sector winds down, join our exclusive panel of all-star reporters for their unique take on the news, trends and issues that will reverberate in 2018 and beyond. Get a fresh take from them on the top newsmakers and analysis of the week's biggest stories heard in and around Union Square.

SPECIAL PROGRAMS / RECEPTIONS

Generation Genome and Industrial Strategy: Leveraging UK Leadership in Genomics

Monday, January 8, 2:00-2:45pm 
Parc 55 San Francisco, Level 3,  Market Street

This panel will bring together representatives from Genomics England, technology partners, SMEs and the venture community to debate the opportunities and challenges that will shape the growth of the UK’s genomics industry and its impact worldwide.

Australia's 43.5% R&D Refund and Simplified Regulatory Environment as a Gateway to Asia

Tuesday, January 9 January, 6:30 pm
Parc 55 San Francisco, Level 3, Market Street

Understanding biotech companies are driven the need to access fast approval timelines and increasing cost efficiencies, Novotech CRO and CoSec Consulting will present research demonstrating how Australia’s supportive clinical trial environment is able to deliver R&D benefits up to 28% cheaper before and 60% after than the US.

Additional Events

China Showcase

Sunday, January 7, 10:00 am - 4:30 pm
Parc 55 San Francisco, Level 4, Cyril Magnin Ballroom

TAP INTO CROSS-BORDER INVESTMENT AND COLLABORATION OPPORTUNITIES AT CHINA SHOWCASE!
Meet and network with top bio pharmaceutical companies and investors seeking global opportunities during Biotech Showcase.

Digital Medicine & Medtech Showcase

Monday -  Wednesday, January 8-10
Parc 55 San Francisco, Level 4, Cyril Magnin Ballroom

INNOVATE. CONNECT. FUND.
At the intersection of technology and medicine: Digital Medicine & Medtech Showcase